v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 6,728,430 $ 25,845,915
Restricted cash 0 10,000,000
Accounts receivable, less allowance for credit losses of $0.2 million and $0.2 million as of March 31, 2024 and December 31, 2023, respectively 1,767,887 4,470,209
Inventory, net 49,852,378 45,408,192
Prepaid expenses and other current assets 7,293,787 8,101,162
Total current assets 65,642,482 93,825,478
Property, plant and equipment, net 38,537,214 37,876,955
Lease right-of-use assets 9,513,950 9,795,981
Other assets 176,310 176,310
Total Assets 113,869,956 141,674,724
Current liabilities:    
Accounts payable 14,229,542 12,456,272
Accrued and other current liabilities 6,652,042 4,862,740
Deferred revenue, current 4,689,581 4,714,331
Warranty liability 599,227 1,902,647
Current portion of lease liabilities 3,416,636 3,560,612
Warrant liability 3,937,540 5,605,325
Current portion of convertible notes 7,874,051 20,180,100
Total current liabilities 41,398,619 53,282,027
Lease liabilities, long-term 5,047,565 5,280,526
Total Liabilities 46,446,184 58,562,553
Commitments and contingencies
Stockholders’ Equity:    
Series A preferred stock, par value $0.001 per share, 75,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock, par value $0.001 per share, 450,000,000 shares authorized, 330,791,980 shares issued and outstanding as of March 31, 2024 and 285,980,843 shares issued and outstanding as of December 31, 2023 330,792 285,981
Additional paid-in capital 847,817,018 834,394,441
Accumulated deficit (780,724,038) (751,568,251)
Total stockholders’ equity 67,423,772 83,112,171
Total Liabilities and Stockholders’ Equity $ 113,869,956 $ 141,674,724

Source

HTML PDF
ZIP